Document is current
Any future updates will be listed below
-
Authors
Wattanathamsan, Onsurang
Chantaravisoot, Naphat
Wongkongkathep, Piriya
Kungsukool, Sakkarin
Chetprayoon, Paninee
Chanvorachote, Pithi
Vinayanuwattikun, Chanida
Pongrakhananon, Varisa https://orcid.org/0000-0002-2220-0842
-
Funding
Funding for this research was provided by:
National Research Council of Thailand (N41A640133)
Second Century Fund, Chulalongkorn University
- License Information
-
More Information
Article History
Received: 18 May 2022
Accepted: 6 January 2023
First Online: 13 January 2023
Declarations
:
: Patient-derived malignant cancer cells were obtained from pleural effusions from patients with recurrent or advanced-stage NSCLC. The study was approved by the Ethics Committee of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (IRB 365/62), and was performed in accordance with the principles of the World Medical Association Declaration of Helsinki. Primary malignant lung tissues and benign lung tissues were obtained during surgical resection at the Central Chest Institute of Thailand, Muang District, Nonthaburi, Thailand. This study was approved by the Ethical Committee of the Central Chest Institute of Thailand (086/2563) and performed in accordance with relevant regulations and guidelines. Written informed consent was obtained from all participants before the start of the study.
: Not applicable.
: The authors declare no competing interest.
